Cargando…
Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029018/ https://www.ncbi.nlm.nih.gov/pubmed/35452191 http://dx.doi.org/10.1002/ctm2.813 |
| _version_ | 1784691772311470080 |
|---|---|
| author | Azorin, Paula Bonin, Florian Tariq, Zakia Petitalot, Ambre Coussy, Florence Marangoni, Elisabetta Becette, Veronique Denoux, Yves Vincent‐Salomon, Anne Le Tourneau, Christophe Larbi Cherif, Linda Klijanienko, Jerzy Kamal, Maud Bièche, Ivan Lidereau, Rosette Driouch, Keltouma |
| author_facet | Azorin, Paula Bonin, Florian Tariq, Zakia Petitalot, Ambre Coussy, Florence Marangoni, Elisabetta Becette, Veronique Denoux, Yves Vincent‐Salomon, Anne Le Tourneau, Christophe Larbi Cherif, Linda Klijanienko, Jerzy Kamal, Maud Bièche, Ivan Lidereau, Rosette Driouch, Keltouma |
| author_sort | Azorin, Paula |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9029018 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90290182022-05-24 Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types Azorin, Paula Bonin, Florian Tariq, Zakia Petitalot, Ambre Coussy, Florence Marangoni, Elisabetta Becette, Veronique Denoux, Yves Vincent‐Salomon, Anne Le Tourneau, Christophe Larbi Cherif, Linda Klijanienko, Jerzy Kamal, Maud Bièche, Ivan Lidereau, Rosette Driouch, Keltouma Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-04-22 /pmc/articles/PMC9029018/ /pubmed/35452191 http://dx.doi.org/10.1002/ctm2.813 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Azorin, Paula Bonin, Florian Tariq, Zakia Petitalot, Ambre Coussy, Florence Marangoni, Elisabetta Becette, Veronique Denoux, Yves Vincent‐Salomon, Anne Le Tourneau, Christophe Larbi Cherif, Linda Klijanienko, Jerzy Kamal, Maud Bièche, Ivan Lidereau, Rosette Driouch, Keltouma Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types |
| title | Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types |
| title_full | Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types |
| title_fullStr | Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types |
| title_full_unstemmed | Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types |
| title_short | Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types |
| title_sort | kindlin‐1 modulates the egfr pathway and predicts sensitivity to egfr inhibitors across cancer types |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029018/ https://www.ncbi.nlm.nih.gov/pubmed/35452191 http://dx.doi.org/10.1002/ctm2.813 |
| work_keys_str_mv | AT azorinpaula kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT boninflorian kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT tariqzakia kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT petitalotambre kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT coussyflorence kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT marangonielisabetta kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT becetteveronique kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT denouxyves kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT vincentsalomonanne kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT letourneauchristophe kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT larbicheriflinda kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT klijanienkojerzy kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT kamalmaud kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT biecheivan kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT lidereaurosette kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes AT driouchkeltouma kindlin1modulatestheegfrpathwayandpredictssensitivitytoegfrinhibitorsacrosscancertypes |